Jim Simons
TTNP

Jim Simons’s Titan Pharmaceuticals TTNP Stock Holding History

Jim Simons’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,380
Closed -$47.8K – 3937
2025
Q2 		$47.8K Buy
+11,380
New +$48.3K ﹤0.01% 3398
2024
Q4 		– Sell
-11,066
Closed -$58.3K – 3923
2024
Q3 		$58.3K Buy
+11,066
New +$63.5K ﹤0.01% 3329
2024
Q1 		– Sell
-6,766
Closed -$56K – 4091
2023
Q4 		$56K Sell
6,766
-20
-0.3% -$149 ﹤0.01% 3435
2023
Q3 		$64K Buy
6,786
+5
+0.1% +$54 ﹤0.01% 3350
2023
Q2 		$88K Buy
6,781
+10
+0.1% +$153 ﹤0.01% 3505
2023
Q1 		$112K Buy
6,771
+50
+0.7% +$895 ﹤0.01% 3457
2022
Q4 		$105K Sell
6,721
-515
-7% -$9.74K ﹤0.01% 3602
2022
Q3 		$156K Sell
7,236
-4,800
-40% -$124K ﹤0.01% 3461
2022
Q2 		$135K Buy
12,036
+10,210
+559% +$127K ﹤0.01% 3764
2022
Q1 		$35K Buy
1,826
+850
+87% +$17.7K ﹤0.01% 3954
2021
Q4 		$20K Buy
976
+326
+50% +$9.82K ﹤0.01% 3839
2021
Q3 		$24K Buy
+650
New +$28.5K ﹤0.01% 3405
2020
Q1 		– Sell
-534
Closed -$62K – 3801
2019
Q4 		$62K Buy
+534
New +$64.3K ﹤0.01% 3374
2019
Q1 		– Sell
-72
Closed -$58K – 3704
2018
Q4 		$58K Sell
72
-124
-63% -$139K ﹤0.01% 3281
2018
Q3 		$146K Buy
196
+16
+9% +$43.5K ﹤0.01% 3204
2018
Q2 		$707K Buy
180
+13
+8% +$43.5K ﹤0.01% 2724
2018
Q1 		$632K Buy
167
+14
+9% +$58.5K ﹤0.01% 2835
2017
Q4 		$732K Buy
153
+31
+25% +$193K ﹤0.01% 2783
2017
Q3 		$771K Buy
122
+45
+58% +$279K ﹤0.01% 2666
2017
Q2 		$530K Buy
77
+11
+17% +$102K ﹤0.01% 2747
2017
Q1 		$781K Buy
66
+25
+61% +$352K ﹤0.01% 2628
2016
Q4 		$586K Buy
+41
New +$690K ﹤0.01% 2725
2016
Q1 		– Sell
-17
Closed -$275K – 3534
2015
Q4 		$275K Buy
+17
New +$277K ﹤0.01% 2910

Other funds holding TTNP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jim Simons's TTNP Position: Q3 2025 in Review

Jim Simons sold out of Titan Pharmaceuticals (TTNP) in Q3 2025, closing a stake of 11,380 shares — an estimated $47.8K sold.

Jim Simons first reported a position in TTNP in Q4 2015 and held it in 23 quarters. The position peaked at $781K in Q1 2017. 18 funds tracked by Wall St. Rank hold TTNP as of Q3 2025.

  • Jim Simons reported no remaining Titan Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Jim Simons sold 11,380 Titan Pharmaceuticals shares in Q3 2025, an estimated $47.8K.
  • Jim Simons first reported a position in Titan Pharmaceuticals in Q4 2015 and held it in 23 quarters.
  • Jim Simons's Titan Pharmaceuticals position peaked at $781K in Q1 2017.
  • 18 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.